{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:52:21Z","timestamp":1790797941816,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","oraloncology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Oncology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.oraloncology.2016.02.014","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T09:00:40Z","timestamp":1458291640000},"page":"25-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Oncolytic adenoviruses targeted to Human Papilloma Virus-positive head and neck squamous cell carcinomas"],"prefix":"10.1016","volume":"56","author":[{"given":"Christopher J.","family":"LaRocca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joohee","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda O.","family":"Salzwedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Davydova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Herzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajaram","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oraloncology.2016.02.014_b0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0010","doi-asserted-by":"crossref","first-page":"c4684","DOI":"10.1136\/bmj.c4684","article-title":"Head and neck cancer\u2013Part 1: epidemiology, presentation, and prevention","volume":"341","author":"Mehanna","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0015","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.oraloncology.2013.12.019","article-title":"Epidemiology of HPV-associated oropharyngeal cancer","volume":"50","author":"Pytynia","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0020","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.oraloncology.2014.03.010","article-title":"HPV and head and neck cancers: state-of-the-science","volume":"50","author":"Fakhry","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0030","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.seminoncol.2004.09.011","article-title":"Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity","volume":"31","author":"Gillison","year":"2004","journal-title":"Semin Oncol"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0040","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijrobp.2010.08.031","article-title":"Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy","volume":"82","author":"Huang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0045","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hed.21997","article-title":"Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status","volume":"34","author":"Spector","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0050","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/jnci\/djg107","article-title":"Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study","volume":"95","author":"Herrero","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0055","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/jcp.2007.052027","article-title":"Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis","volume":"61","author":"Huang","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0060","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1002\/j.1460-2075.1988.tb03185.x","article-title":"Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma","volume":"7","author":"Schlegel","year":"1988","journal-title":"EMBO J"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0065","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1128\/JVI.63.10.4417-4421.1989","article-title":"The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes","volume":"63","author":"Munger","year":"1989","journal-title":"J Virol"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0070","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1002\/j.1460-2075.1989.tb08570.x","article-title":"HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes","volume":"8","author":"Hawley-Nelson","year":"1989","journal-title":"EMBO J"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0075","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","article-title":"The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53","volume":"63","author":"Scheffner","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.2157286","article-title":"Association of human papillomavirus types 16 and 18 E6 proteins with p53","volume":"248","author":"Werness","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0085","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1128\/JVI.73.8.6209-6219.1999","article-title":"The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP\/p300","volume":"73","author":"Zimmermann","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0090","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.2537532","article-title":"The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product","volume":"243","author":"Dyson","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0095","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1073\/pnas.89.10.4549","article-title":"Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product","volume":"89","author":"Chellappan","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/(SICI)1097-4644(19970901)66:3<277::AID-JCB1>3.0.CO;2-M","article-title":"Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity","volume":"66","author":"Sang","year":"1997","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0092-8674(89)90984-7","article-title":"Cellular targets for transformation by the adenovirus E1A proteins","volume":"56","author":"Whyte","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.onc.1203251","article-title":"A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo","volume":"19","author":"Fueyo","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0115","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1128\/JVI.75.16.7602-7611.2001","article-title":"Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes","volume":"75","author":"Balague","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/mthe.2001.0447","article-title":"Human papilloma virus E6 and E7 proteins support DNA replication of adenoviruses deleted for the E1A and E1B genes","volume":"4","author":"Steinwaerder","year":"2001","journal-title":"Mol Ther"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0125","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/JVI.70.1.332-340.1996","article-title":"The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity","volume":"70","author":"Wong","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0130","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1349-7006.2009.01407.x","article-title":"In vivo bioimaging tracks conditionally replicative adenoviral replication and provides an early indication of viral antitumor efficacy","volume":"101","author":"Davydova","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.surg.2012.02.017","article-title":"Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy","volume":"152","author":"Armstrong","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0140","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1158\/0008-5472.CAN-04-0064","article-title":"Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment","volume":"64","author":"Davydova","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0204s82","article-title":"Production of polyclonal antisera","author":"Cooper","year":"2008","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0150","doi-asserted-by":"crossref","first-page":"15544","DOI":"10.1073\/pnas.1416074111","article-title":"Characterization of HPV and host genome interactions in primary head and neck cancers","volume":"111","author":"Parfenov","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0155","first-page":"2571","article-title":"Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector","volume":"5","author":"Kasono","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0160","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/jgm.957","article-title":"Head and neck cancer cells are efficiently infected by Ad5\/35 hybrid virus","volume":"8","author":"Suominen","year":"2006","journal-title":"J Gene Med"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0165","first-page":"1057","article-title":"Coxsackie adenovirus receptor expression in carcinomas of the head and neck","volume":"32","author":"Wunder","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.cgt.7700529","article-title":"Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer","volume":"10","author":"Dehari","year":"2003","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mt.2009.266","article-title":"Current issues and future directions of oncolytic adenoviruses","volume":"18","author":"Yamamoto","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0180","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0185","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1099\/vir.0.83142-0","article-title":"Species B adenovirus serotypes 3, 7, 11 and 35 share similar binding sites on the membrane cofactor protein CD46 receptor","volume":"88","author":"Fleischli","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0190","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1128\/JVI.78.9.4454-4462.2004","article-title":"The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3","volume":"78","author":"Sirena","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2001.19.2.289","article-title":"Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer","volume":"19","author":"Nemunaitis","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0200","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ygyno.2013.06.003","article-title":"A phase I clinical trial of Ad5\/3-Delta24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer","volume":"130","author":"Kim","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.oraloncology.2016.02.014_b0205","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1158\/1078-0432.CCR-10-0791","article-title":"A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases","volume":"16","author":"Kimball","year":"2010","journal-title":"Clin Cancer Res"}],"container-title":["Oral Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368837516000439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368837516000439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T05:13:11Z","timestamp":1600319591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368837516000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":41,"alternative-id":["S1368837516000439"],"URL":"https:\/\/doi.org\/10.1016\/j.oraloncology.2016.02.014","relation":{},"ISSN":["1368-8375"],"issn-type":[{"value":"1368-8375","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncolytic adenoviruses targeted to Human Papilloma Virus-positive head and neck squamous cell carcinomas","name":"articletitle","label":"Article Title"},{"value":"Oral Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oraloncology.2016.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}